Follow The Filings

OPCH Option Care Health

Option Care Health earnings company data as of 3:58 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 0.44 — —
Rev — — —

Insider trades

Open-market buys and sales by OPCH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All OPCH insider trades
  • $2.9M bought by 4 insiders
  • $1.2M sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Timothy P Sullivan Director
    Buy
    $500K 24,154 shares at $20.69 +49% to stake
    Traded May 7 Filed May 7
  2. Harry M Jansen Kraemer Jr. Director
    Buy
    $784K 36,610 shares at $21.41 +8.9% to stake
    Traded May 4 Filed May 5
  3. Meenal Sethna CFO
    Buy
    $327K 16,225 shares at $20.16 +20% to stake
    Traded May 4 Filed May 4
  4. John Charles Rademacher CEO
    Buy
    $265K 12,500 shares at $21.18 +1.8% to stake
    Traded May 4 Filed May 4
  5. R Carter Pate Director
    Sale
    $971K 30,287 shares at $32.05 72% of stake
    Traded Feb 27 Filed Mar 3
  6. Michael Bavaro Chief Human Resources Officer
    Sale
    $198K 6,000 shares at $33.00 15% of stake
    Traded Feb 27 Filed Mar 3
  7. Harry M Jansen Kraemer Jr. Director
    Buy
    $987K 38,000 shares at $25.98 +10% to stake
    Traded Nov 3, 2025 Filed Nov 4, 2025

Also filed in the last 12 months, not counted as buying or selling: 26 share withholdings for taxes, 22 stock grants, and 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
DEFA14A
DEFA14A
8-K 1.01,7.01,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 5.07
8-K 7.01,9.01
SCHEDULE 13G/A —
8-K 5.02
SCHEDULE 13G —
8-K 2.02,7.01,9.01
10-Q
SCHEDULE 13G —
DEF 14A
DEFA14A
8-K 1.01,2.03,9.01
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.